Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
about
Searching for the human genetic factors standing in the way of universally effective vaccinesGenetics of gene expression in immunity to infectionAssociations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination.Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccinationThe genetic regulation of infant immune responses to vaccination.Integrative network analysis reveals different pathophysiological mechanisms of insulin resistance among Caucasians and African AmericansProfiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination.High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.Variability in Humoral Immunity to Measles Vaccine: New Developments.The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approachesVariation between Populations in the Innate Immune Response to Vaccine Adjuvants.Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationAssociations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa.Impact of host genetic polymorphisms on vaccine induced antibody responseAssociations between race, sex and immune response variations to rubella vaccination in two independent cohorts.Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue.Polymorphisms in the retinoic acid-1 like-receptor family of genes and their association with clinical outcome of dengue virus infection.Role of Sequencing the Measles Virus Hemagglutinin Gene and Hypervariable Region in the Measles Outbreak Investigations in Sweden During 2013-2014.Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.Heritability of vaccine-induced measles neutralizing antibody titers.RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections.
P2860
Q27007034-2C61C22F-3115-471E-80C7-D0F1C6307708Q28647767-2BFA7B5D-92F2-48D2-A646-CDEE919FC0C3Q33778981-1107F473-C258-4303-A8A2-05A959D47DEBQ34057942-6D5D5E04-5AA3-43CB-B801-17D0AD704548Q34126261-0A664989-CD97-45DF-964A-5B2D7E17ACC2Q34345266-1569C835-2D74-4331-B0E0-5A96DAF1F0DDQ34599856-4F48AACD-9C1B-4915-AE1F-33E765E202F4Q35037615-7A19BF22-6B39-4FA1-9ED4-3D9B71795033Q35154573-E48851E3-85C6-4432-AA14-EBA614E07526Q35232801-2E639145-3EB8-405D-B710-55617F9F7CDBQ35245144-A9148EE2-20EF-4847-8785-7A9660CB1FB9Q35784185-53D2B0CD-28EE-4967-AE72-992AFACE8642Q36104082-10BCA5AD-75A9-4447-9738-76A27804E3C2Q36105040-323A4FA1-93F0-419E-B42A-1BB31670852FQ36330959-7C67AFB3-3431-4218-9FA7-0418BEF91BB2Q36373260-6EA75F82-3936-41E9-8577-25F1CDAC81BEQ36603325-A92CB124-A260-475D-B9CF-E75FB1318C7CQ36733384-CACE1E51-FC0D-4EF7-A27E-ADC6F318080DQ36733960-2D1FCD00-70C8-4D42-ACD0-592AA99FFCD8Q36816196-CA56A04D-2D43-4854-A3A1-9427EDF03F35Q36947272-EAFDAB53-6E1F-4966-B87A-EC36E8F7223BQ37130716-9A9BA5F2-242C-4606-B940-15DE650725E0Q37693231-DA7BCCB7-22C0-4F66-9E33-D0BE2AB5F2B1Q38910093-C95EAAB7-FB80-41F1-A8AC-3EDC27C556EAQ39221090-67B3DD51-5CAF-4C0B-BCA9-81ADC9A7A563Q40111809-2287D4A6-13DF-4D62-AF1A-9F31919DFF9CQ40152182-C88B966E-05C5-4386-A8B6-123334F26C60Q40161821-7C5E4AD6-6660-468F-91C3-BA795D47A318Q40564424-B4DDADBC-D9F5-483B-9B47-0A404D024CD7Q47281345-B25301D0-EA2A-4517-AA73-AC81ACD0A3EFQ47547879-72B5F82C-F6DF-44D7-AD10-F58F9AFFC880Q47892454-593516E8-A271-4EB2-A7FC-3AFFC7247CC0Q55454646-3F15FC81-644F-4480-9B9E-6EE9AE9A65B1
P2860
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic polymorphisms in host ...... r immunity to measles vaccine.
@en
Genetic polymorphisms in host ...... r immunity to measles vaccine.
@nl
type
label
Genetic polymorphisms in host ...... r immunity to measles vaccine.
@en
Genetic polymorphisms in host ...... r immunity to measles vaccine.
@nl
prefLabel
Genetic polymorphisms in host ...... r immunity to measles vaccine.
@en
Genetic polymorphisms in host ...... r immunity to measles vaccine.
@nl
P2093
P2860
P50
P1433
P1476
Genetic polymorphisms in host ...... ar immunity to measles vaccine
@en
P2093
Benjamin J Umlauf
Gregory A Poland
V Shane Pankratz
P2860
P304
P356
10.1016/J.VACCINE.2011.09.043
P407
P577
2011-09-20T00:00:00Z